Investors Might Need A Waste Bag For Freshpet's Stock

Despite a 45% year-to-date decline, Freshpet (FRPT) remains a risky investment due to persistently high operating costs, significant cash burn, and lagging market share against larger, more profitable competitors like Nestle and Mars. First quarter 2025 earnings missed estimates, and full-year adjusted EBITDA guidance was lowered to $190-$210 million. The current stock valuation implies Freshpet must significantly increase its market share and profitability to levels not yet achieved, with DCF analyses indicating a potential downside of 40% to over 65% even under optimistic growth scenarios.

Analysis

Freshpet Inc. (FRPT) continues to present a high-risk profile for investors, despite a 45% year-to-date stock price decline. While the company reported an 18% year-over-year revenue increase in 1Q25, driven predominantly by a 15% volume gain, fundamental weaknesses persist. Freshpet missed 1Q25 earnings estimates and revised its full-year adjusted EBITDA guidance downwards to $190-$210 million from "at least $210 million." The firm's preferred metric, adjusted EBITDA, which rose from $31 million in 1Q24 to $36 million in 1Q25, is potentially misleading as it excludes significant items like $8.8 million in non-cash share-based compensation in 1Q25; consequently, while adjusted EBITDA improved from $29 million in 2019 to $167 million TTM, economic earnings deteriorated from -$11 million to -$88 million over the same period, and 1Q25 GAAP net income was -$13 million. Operating costs remain a critical concern, averaging 106% of revenue over the last five years and rising to 104% in 1Q25 from 96% in 1Q24, largely due to SG&A expenses increasing from 36% to 44% of revenue. This operational inefficiency contributes to a substantial and consistent cash burn, with Freshpet accumulating a negative free cash flow of $1.2 billion since 2019. The company holds a mere 1% market share in the pet food industry, which is dominated by significantly larger and more profitable entities such as Nestle (32% market share) and Mars (29% market share). Freshpet's profitability metrics, with a net operating profit after-tax (NOPAT) falling to -$10 million in 1Q25 from $9 million in 1Q24 and a TTM return on invested capital (ROIC) of 2%, lag industry peers. The current stock valuation implies extraordinary future performance, requiring Freshpet to grow its market share sevenfold and achieve unprecedented profit levels—a reverse DCF analysis suggests the stock price bakes in NOPAT reaching $608 million, compared to an all-time high of $50 million. Even more conservative DCF scenarios indicate potential downsides of 40% to over 68%, with the company's economic book value calculated at less than $1 per share.

Key Decisions for Investors

• Given Freshpet's persistent negative free cash flow, high operating expenses relative to revenue, and lowered full-year guidance, investors should view the stock with extreme caution and consider the significant risks outlined.
• The current valuation appears highly optimistic, requiring substantial market share gains and margin improvements that are not supported by historical performance or current industry dynamics; therefore, investors should be aware of the considerable downside potential highlighted by the DCF analysis.
• Investors should critically evaluate the company's reliance on adjusted EBITDA, monitor GAAP net income and economic earnings for a clearer picture of financial health, and watch for any further depletion of cash reserves that could shorten its operational runway, especially following Jana Partners' exit.